CF Foundation Awards Over $2 Million for Cystic Fibrosis Treatment Development
source: pixabay.com

CF Foundation Awards Over $2 Million for Cystic Fibrosis Treatment Development

The Cystic Fibrosis Foundation is dedicated to finding a cure for the rare, genetic disorder. They fund more CF research than any other organization, and their latest effort is a…

Continue Reading CF Foundation Awards Over $2 Million for Cystic Fibrosis Treatment Development

New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections

Non-tuberculous mycobacterial (NTM) infections are caused by bacteria found in the environment. In healthy individuals, these bacteria normally cause no harm. However, for those who have a compromised immune system or who…

Continue Reading New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections

Interim Results from Phase 2a Trial for Nontuberculous Mycobacterial Lung Disease Bring Hope

Nontuberculous mycobacterial (NTM) lung infection occurs when someone inhales nontuberculous mycobacteria from the environment. There are various types of this bacteria, giving NTM different forms. But in all types of NTM,…

Continue Reading Interim Results from Phase 2a Trial for Nontuberculous Mycobacterial Lung Disease Bring Hope